Targeting the splice factor kinases SRPK1 and CLK1 in leukaemia
(2021)
Thesis
This study was aimed at investigating the effect of inhibiting SRPK1 in leukaemic cells. It was also aimed at exploring the potential utility of combining conventional leukaemia chemotherapy (such as imatinib) with compounds that inhibit SRPK1.
SR...
Read More about Targeting the splice factor kinases SRPK1 and CLK1 in leukaemia.